|
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
RECRUITINGSponsored by Yale University
Actively Recruiting
SponsorYale University
Started2021-06-28
Est. completion2026-01-30
Eligibility
Age12 Years – 18 Years
Locations1 site
View on ClinicalTrials.gov →
NCT04634643
Summary
The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
Eligibility
Age: 12 Years – 18 Years
Inclusion Criteria: * Good general health, taking no medication on a chronic basis; * age 12 to 18 years, in puberty (girls and boys: Tanner stage II-V); * BMI \>85th for obese cohort; Exclusion Criteria: * Baseline creatinine \>1.0 mg; pregnancy; * the presence of endocrinopathies (e.g. Cushing syndrome); * cardiac or pulmonary or other significant chronic illness; * adolescents with a psychiatric disorder or with substance abuse; * monogenic obesity syndromes; * use of drugs affecting intrahepatic fat content (e.g.; liraglutide, fish oil, etc.).
Conditions2
Liver DiseaseNAFLD
Locations1 site
Yale New Haven Hospital
New Haven, Connecticut, 06510
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorYale University
Started2021-06-28
Est. completion2026-01-30
Eligibility
Age12 Years – 18 Years
Locations1 site
View on ClinicalTrials.gov →
NCT04634643